4th Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 Discussion draft; Laboratory Access for Beneficiaries Act, (H.R. 3584/S. 3049).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3049 (116th), H.R. 3584 (116th)

Health Issues HCR

The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 Discussion draft; Laboratory Access for Beneficiaries Act, (H.R. 3584/S. 3049).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3049 (116th), H.R. 3584 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.